Summary: 1. First Trust Low Duration Opportunities ETF focuses on short-term bonds to provide a stable yield for…
Intellia Therapeutics, a biotech company focusing on CRISPR-based therapies for rare diseases and oncology, recently disclosed a significant…
Summary: 1. Claudio Tuozzolo, Corporate Vice President at Vicor, exercised 20,145 stock options and sold the resulting shares.…
Sign in to your account